Ignite Creation Date:
2025-12-24 @ 10:12 PM
Ignite Modification Date:
2025-12-25 @ 7:47 PM
Study NCT ID:
NCT04620135
Status:
COMPLETED
Last Update Posted:
2023-02-27
First Post:
2020-10-26
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular Hypertension
Sponsor:
Aerie Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2021-07-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-07-30
Completion Date Type:
ACTUAL
First Submit Date:
2020-10-26
First Submit QC Date:
None
Study First Post Date:
2020-11-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-12-13
Results First Submit QC Date:
None
Results First Post Date:
2023-02-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-01
Last Update Post Date:
2023-02-27
Last Update Post Date Type:
ACTUAL